{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:04:09Z","timestamp":1787828649563,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.humpath.2017.11.020","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T01:16:15Z","timestamp":1513041375000},"page":"41-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone"],"prefix":"10.1016","volume":"73","author":[{"given":"Hidetaka","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.11.020_bb0005","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","first-page":"321","article-title":"Giant cell tumour of bone","author":"Athanasou","year":"2013"},{"key":"10.1016\/j.humpath.2017.11.020_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.anndiagpath.2007.09.002","article-title":"Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India","volume":"12","author":"Gupta","year":"2008","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bone.2012.10.002","article-title":"Giant cell tumor of bone: a basic science perspective","volume":"52","author":"Cowan","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.humpath.2017.11.020_bb0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00776-005-0946-0","article-title":"Osteoblast lineage properties in giant cell tumors of bone","volume":"10","author":"Murata","year":"2005","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.humpath.2017.11.020_bb0025","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/cncr.11359","article-title":"Malignancy in giant cell tumor of bone","volume":"97","author":"Bertoni","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2017.11.020_bb0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00428-012-1198-y","article-title":"Histological and clinical characteristics of malignant giant cell tumor of bone","volume":"460","author":"Gong","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2017.11.020_bb0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study","volume":"14","author":"Chawla","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0040","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/annonc\/mdv307","article-title":"Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial","volume":"26","author":"Ueda","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0045","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone","volume":"18","author":"Branstetter","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2017.11.020_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0000000000000506","article-title":"Denosumab-treated giant cell tumor of bone exhibits morphologic overlap with malignant giant cell tumor of bone","volume":"40","author":"Wojcik","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.01.006","article-title":"Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone","volume":"59","author":"Traub","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2017.11.020_bb0060","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2017.11.020_bb0065","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics","volume":"1","author":"Presneau","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.humpath.2017.11.020_bb0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2016.212","article-title":"H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach","volume":"30","author":"Kervarrec","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0080","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2017.11.020_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00412-015-0510-4","article-title":"Histone H3 mutations\u2014a special role for H3.3 in tumorigenesis?","volume":"124","author":"Kallappagoudar","year":"2015","journal-title":"Chromosoma"},{"key":"10.1016\/j.humpath.2017.11.020_bb0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00401-014-1338-3","article-title":"A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas","volume":"128","author":"Venneti","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12945","article-title":"The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma","volume":"69","author":"Amary","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2017.11.020_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2013.03.005","article-title":"USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis","volume":"45","author":"Oliveira","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/gcc.20501","article-title":"Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors","volume":"47","author":"M\u00f6ller","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2017.11.020_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jclinpath-2015-203248","article-title":"Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series","volume":"69","author":"Girolami","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2017.11.020_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant","volume":"71","author":"L\u00fcke","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2017.11.020_bb0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1359\/jbmr.2002.17.2.257","article-title":"Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor","volume":"17","author":"Kubota","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.humpath.2017.11.020_bb0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bone.2003.10.013","article-title":"Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone","volume":"34","author":"Huang","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.humpath.2017.11.020_bb0135","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/jbmr.5650111012","article-title":"Human osteoclastoma-derived stromal cells: correlation of the ability to form mineralized nodules in vitro with formation of bone in vivo","volume":"11","author":"James","year":"1996","journal-title":"J Bone Miner Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T08:31:30Z","timestamp":1530261090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717304665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"alternative-id":["S0046817717304665"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.11.020","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}